MYO - Myomo to Report First Quarter Financial Results on May 14 2020

Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today announced that it will report financial results for the first quarter ended March 31, 2020 on Thursday, May 14, 2020 after the market close.

The Company will host a conference call the same day, Thursday, May 14, 2020 at 4:30 p.m. ET with prepared remarks by Paul R. Gudonis, chairman and chief executive officer, and David Henry, chief financial officer. The conference call webcast can be accessed here. Please allow extra time prior to the call to visit the site and download any necessary software to listen to the live broadcast.

To access the live conference call, please dial 1-844-707-6932 (U.S.). or 1-412-317-9250 (International). A webcast replay of the conference call will be available approximately one hour after completion at the Investor Relations page. A dial-in replay of the call will be available until May 28, 2020; please dial 1-877-344-7529 (U.S.) 1-412-317-0088 (International) and provide the passcode #10143817.

About Myomo

Myomo, Inc. is a wearable medical robotics company that offers improved arm and hand function for those suffering from neurological disorders and upper limb paralysis. Myomo develops and markets the MyoPro product line. MyoPro is a powered upper limb orthosis designed to support the arm and restore function to the weakened or paralyzed arms of patients suffering from CVA stroke, brachial plexus injury, traumatic brain or spinal cord injury, ALS or other neuromuscular disease or injury. It is currently the only marketed device that, sensing a patient’s own EMG signals through non-invasive sensors on the arm, can restore an individual’s ability to perform activities of daily living, including feeding themselves, carrying objects and doing household tasks. Many are able to return to work, live independently and reduce their cost of care. Myomo is headquartered in Cambridge, Massachusetts, with sales and clinical professionals across the U.S. and representatives internationally. For more information, please visit www.myomo.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200512005861/en/